Conmed (CNMD) EPS (Weighted Average and Diluted) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.74% |
| Dec 31, 2025 | -7.79% |
| Sep 30, 2025 | -17.11% |
| Jun 30, 2025 | 22.14% |
| Mar 31, 2025 | -1.02% |
| Dec 31, 2024 | 17.12% |
| Sep 30, 2024 | 46.84% |
| Jun 30, 2024 | 38.26% |
| Mar 31, 2024 | 73.56% |
| Dec 31, 2023 | 14.22% |
| Sep 30, 2023 | 20.11% |
| Jun 30, 2023 | 7.47% |
| Mar 31, 2023 | -30.50% |
| Dec 31, 2022 | -11.22% |
| Sep 30, 2022 | 41.60% |
| Jun 30, 2022 | -94.28% |
| Mar 31, 2022 | 37.63% |
| Dec 31, 2021 | 25.59% |
| Sep 30, 2021 | 12.57% |
| Jun 30, 2021 | 32.60% |
| Mar 31, 2021 | 42.50% |
| Dec 31, 2020 | 23.67% |
| Sep 30, 2020 | -6.39% |
| Jun 30, 2020 | -40.91% |
| Mar 31, 2020 | -2.76% |
| Dec 31, 2019 | 3.63% |
| Sep 30, 2019 | 26.86% |
| Jun 30, 2019 | -12.48% |
| Mar 31, 2019 | -33.60% |
| Dec 31, 2018 | 8.45% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | -2.47% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 34.13% |
| Sep 30, 2017 | -4.07% |
| Jun 30, 2017 | -9.38% |
| Mar 31, 2017 | -19.70% |
| Dec 31, 2016 | 17.78% |
| Sep 30, 2016 | -2.16% |
| Jun 30, 2016 | -19.73% |
| Mar 31, 2016 | -17.69% |
| Dec 31, 2015 | 3.13% |
| Sep 30, 2015 | 0.64% |
| Jun 30, 2015 | 1.55% |